Market & Product Development

Showing 4 posts of 4 posts found.

NICE recommends treatment for chronic kidney disease, IgA nephropathy

May 23, 2025 Market & Product Development, Medical Communications, Research and Development IgA nephropathy, National Institute for Health and Care Excellence, Nephrology, kidney disease

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending CSL Vifor’s FILSPARI (sparsentan) for …
The Gateway to Local Adoption Series

Latest content